Navigation Links
Jiangbo Pharmaceuticals Reports Results for Third Quarter of Fiscal Year 2010
Date:5/17/2010

lated parties -- -- -- 54,500 Total cost of sales 6,974,455 6,853,810 17,901,903 19,759,520 GROSS PROFIT 18,596,934 18,872,027 50,233,482 66,475,753 RESEARCH AND DEVELOPMENT EXPENSE 1,093,440 1,098,675 3,299,400 3,295,125 SELLING, GENERAL AND ADMINISTRATIVE EXPENSES 3,799,136 4,477,356 13,400,155 31,111,752 INCOME FROM OPERATIONS 13,704,358 13,295,996 33,533,927 32,068,876 OTHER (INCOME) EXPENSE: Change in fair value of derivative liabilities (11,624,079) -- (13,490,071) -- Other income - related parties (80,652) (76,552) (241,956) (313,276) Non-operating (income) expense 5,790 (131,104) 220,061 1,062,488 Interest expense, net 6,643,163 1,241,843 15,562,981 4,143,968 Loss from discontinued operations 36,000 103,008 200,769 1,693,830 Total other income (expense), net (5,019,778) 1,137,195 2,251,784 6,587,010 INCOME BEFORE PROVISION FOR INCOME TAXES 18,724,136 12,158,801 31,282,143 25,481,866 PROVISION FOR INCOME TAXES 3,539,870 3,302,953 8,618,061 8,093,320 NET INCOME 15,184,266 8,855,848 22,664,082 17,388,546 OTHER COMPREHENSIVE INCOME: Unrealized holding gain (loss) 32,164 (200,025) 88,535 (2,147,642) Foreign currency translation adjustment 509 (201,173) 197,393 378,284 COMPREHENSIVE INCOME $ 15,184,775 $ 8,654,650 $22,950,010 $15,619,188 BASIC WEIGHTED AVERAGE NUMBER OF SHARES 11,419,991 10,277,762 10,965,346 9,9
'/>"/>
SOURCE Jiangbo Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010
2. Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010
3. Jiangbo Pharmaceuticals Osteomyelitis Treatment Tablets to be Included in Chinas National Insurance Directory
4. Jiangbo Pharmaceuticals Obtains Renewal of GMP Certificate
5. Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results
6. Jiangbo Pharmaceuticals, Inc. Announces Conference Call to Discuss Results for the First Quarter of Fiscal Year 2010
7. Lotus Pharmaceuticals, Inc. Reports Strong First Quarter 2010 Financial Results
8. DUSA Pharmaceuticals Announces Slate of Nominees for Election to the Board of Directors
9. Ferring Pharmaceuticals Announces Disco Icon Gloria Gaynor as National Spokesperson for EUFLEXXA(R)
10. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2010 First Quarter Earnings Conference Call on Monday, May 17, 2010 at 9:30 a.m. ET
11. Jazz Pharmaceuticals Announces Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 31, 2014  A substantial share of pharmacy ... which therapies are included in formularies—say patient support ... a new Manhattan Research study, Taking the ... finds that P&T committee members in hospitals, managed ... have set a high bar for these programs, ...
(Date:7/31/2014)... , July 31, 2014 Catylix, ... Aspira Scientific ( Milpitas, California ) ... to develop and commercialize new fluorination products and ... molecules has benefited from the use of substituents ... combine lipophilicity with polarity to improve binding and ...
(Date:7/31/2014)... Ariz. , July 31, 2014 For ... public can watch the implantation of the SynCardia temporary ... paper and matching video posted on the Journal of ... video and read the paper on the SynCardia Total ... The 16-minute video accompanies "Implantation of the SynCardia Total ...
Breaking Medicine Technology:Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 2Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 3Catylix, Inc. and Aspira Scientific Announce Joint Venture to Commercialize New Fluorination Technologies 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 3
... Md. , May 6 The U.S. Food and Drug Administration ... , , , ... , , ... (estradiol valerate) and a progestin (dienogest), and is the first four-phasic oral contraceptive ...
... An innovative catheter-based procedure is providing relief to patients who suffer ... severely leaky heart valve, but who are too sick for open-chest surgery, ... and Interventions (SCAI) 33rd Annual Scientific Sessions. , ... Data from the Endovascular Valve Edge-to-Edge REpair STudy ...
Cached Medicine Technology:FDA Approves New Combination Product Oral Contraceptive 2MitraClip Safely Relieves Symptoms in Patients With No Surgical Options 2MitraClip Safely Relieves Symptoms in Patients With No Surgical Options 3MitraClip Safely Relieves Symptoms in Patients With No Surgical Options 4
(Date:7/31/2014)... United Theological Seminary will kick off ... September 15, with its 2014 Opening Convocation, to be ... Rd., Kettering, OH. Dr. Emma J. Justes, Distinguished Professor ... Chair will speak on “Unexpected Undercurrents: Responding to Secrets ... research interests include pastoral care and counseling, pastoral theology, ...
(Date:7/31/2014)... 31, 2014 In today’s world, a good ... get. Snoring and sleep apnea (a medical problem where the ... their bed partners of the rest they need to face ... population snores and 20 million people in the United States ... diagnosed and treated; and of those treated, many cannot tolerate ...
(Date:7/31/2014)... Hook Your Ex, a system created by Steve Pratt, who discovered ... their partner, to the point of starvation, that they come back ... taught to hundreds of men and women across the country with ... , Shane Michaels agrees this simple trick is genius and can ... chance at getting back together with their ex. “I was ...
(Date:7/31/2014)... July 31, 2014 NEWwoodworks, fine woodworking ... expanding their brand presence with a website dedicated to ... years, NEWwoodworks has specialized in handcrafted cabinetry, furniture, ... NEWwoodworks has earned a reputation for taking on the ... on. They commonly craft with reclaimed wood, often using ...
(Date:7/31/2014)... Dr. Mohebi was asked about his experience ... of traveling and sharing what we learned through research ... We are now witnessing results that we never thought ... pleasure to communicate this knowledge to our international colleagues.” ... performing FUE transplantation helped inspire many other doctors to ...
Breaking Medicine News(10 mins):Health News:United Theological Seminary to Open 144th Year 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Hook Your Ex Review by Shane Michaels Exposes Steve Pratt And His New Method For Getting Back With The Ex 2Health News:NEWwoodworks Fine Woodworking Group Launches New Website 2Health News:NEWwoodworks Fine Woodworking Group Launches New Website 3Health News:Los Angles Hair Transplant Surgeon, Dr. Parsa Mohebi Inspires Doctors at Global Conferences to Adopt His Novel Method in FUE Hair Transplantation 2
... ANGELES, April 24 SEIU United Healthcare,Workers - West ... have reached a tentative agreement on a new five-year ... more than 570,healthcare workers at MPTF Hospital and Health ... by the SEIU UHW,bargaining committee to its membership, and ...
... cancers that depend on hormones and those that ... 25th in the open-access journal PLoS Genetics. , ... which usually require treatment with surgery and anti-hormone ... hormone independent breast cancers, which are treated with ...
... high-quality care at best cost, study says , , THURSDAY, ... privately insured patients in the United States are being ... is due to physicians who refer patients to their ... find. , For the study, Dr. Jean M. Mitchell, ...
... But survey finds many aren,t prepared to tackle the ... News) -- While most public health department officials in ... warming seriously, the majority say they aren,t prepared to ... percent of local health department directors said they believed ...
... April 24 The U.S. Senate voted,95 to ... ("GINA," H.R.,493), which bars employers and health insurers ... own or their family members, genetic,information, on April ... and Communications at,the U.S. Conference of Catholic Bishops, ...
... for 21st,Century Medicine (http://www.twentyfirstcenturymedicine.org ), a ... diagnostic technology,companies, clinical laboratories, venture capitalists, and ... the passage of the Genetic,Information Nondiscrimination Act ... The House of Representatives passed GINA ...
Cached Medicine News:Health News:Settlement Reached Between Motion Picture & Television Fund and SEIU UHW 2Health News:Increase in Diagnostic Imaging Fueled by Self-Referring Doctors 2Health News:Local Health Officials Recognize Threat of Global Warming 2Health News:Local Health Officials Recognize Threat of Global Warming 3Health News:Coalition for 21st Century Medicine Congratulates U.S. Senate on Passage of Genetic Information Nondiscrimination Act 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: